# Greenwich LifeSciences Shares Gain More Than 25% After Trial Poster News

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/59720
Published: 2026-11-17T18:09:39.000Z
Updated: 2026-11-17T18:09:39.000Z
Section: Business

> Two posters at an upcoming medical event will cover FLAMINGO-01, the company’s Phase 3 cancer trial.

Greenwich LifeSciences, Inc. shares rose more than 25% Tuesday, Nov. 17, after the company disclosed that two posters about its FLAMINGO-01 Phase 3 cancer trial are scheduled for an upcoming medical event.

The company trades on Nasdaq as GLSI.


